REESE DAVID M 4
4 · AMGEN INC · Filed May 11, 2026
Research Summary
AI-generated summary of this filing
Amgen CTO David Reese Withholds 556 Shares for Taxes
What Happened
David M. Reese, EVP & Chief Technology Officer of Amgen (AMGN), had 556 shares disposed of to satisfy a tax liability on May 7, 2026. The shares were recorded at $331.11 each for a total value of $184,097. The transaction is coded "F" (payment of exercise price or tax liability), indicating a withholding/covering of taxes rather than an open-market sale.
Key Details
- Transaction date: 2026-05-07; Price per share: $331.11; Total value: $184,097.
- Shares disposed: 556 (reported as "Disposed" to cover taxes).
- Footnote: 350 of the 556 shares are Dividend Equivalents (DEs) credited to unvested RSUs under Amgen's equity plan and paid out in shares on a one-to-one basis upon vesting.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Filing: Report filed 2026-05-11 (timely under the Form 4 two-business-day rule).
Context
This was a routine tax-withholding transaction tied to equity compensation (RSUs/DEs). Such withholdings are administrative — they reduce the insider's share count to cover taxes and do not necessarily indicate a decision to sell shares on the open market.
Insider Transaction Report
Form 4
AMGEN INCAMGN
REESE DAVID M
EVP & Chief Technology Officer
Transactions
- Tax Payment
Common Stock
[F1]2026-05-07$331.11/sh−556$184,097→ 42,256 total
Footnotes (1)
- [F1]These shares include 350 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Signature
/s/ David M. Reese|2026-05-08